Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the Middle Cerebral Artery M2 Segment | Zendy

Amrou Sarraj | Zendy; Navdeep Sangha | Zendy; Muhammad Shazam Hussain | Zendy; Dolora Wisco | Zendy; Nirav Vora | Zendy; Lucas Elijovich | Zendy; Nitin Goyal | Zendy; Michael Abraham | Zendy; Manoj Mittal | Zendy; Lei Feng | Zendy; Abel Wu | Zendy; Vallabh Janardhan | Zendy; Suman Nalluri | Zendy; Albert J. Yoo | Zendy; Megan George | Zendy; Randall C. Edgell | Zendy; Rutvij Shah | Zendy; Clark Sitton | Zendy; Emilio P. Supsupin | Zendy; Suhas Bajgur | Zendy; Mary Carter Denny | Zendy; Peng R. Chen | Zendy; Mark Dannenbaum | Zendy; Sheryl MartinSchild | Zendy; Sean I. Savitz | Zendy; Rishi Gupta | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the Middle Cerebral Artery M2 Segment

Author(s) -

Amrou Sarraj,

Navdeep Sangha,

Muhammad Shazam Hussain,

Dolora Wisco,

Nirav Vora,

Lucas Elijovich,

Nitin Goyal,

Michael Abraham,

Manoj Mittal,

Lei Feng,

Abel Wu,

Vallabh Janardhan,

Suman Nalluri,

Albert J. Yoo,

Megan George,

Randall C. Edgell,

Rutvij Shah,

Clark Sitton,

Emilio P. Supsupin,

Suhas Bajgur,

Mary Carter Denny,

Peng R. Chen,

Mark Dannenbaum,

Sheryl MartinSchild,

Sean I. Savitz,

Rishi Gupta

Publication year - 2016

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2016.2773

Subject(s) - medicine , modified rankin scale , stroke (engine) , cohort , randomized controlled trial , retrospective cohort study , middle cerebral artery , cardiology , surgery , ischemic stroke , ischemia , mechanical engineering , engineering

Randomized clinical trials have shown the superiority of endovascular therapy (EVT) compared with best medical management for acute ischemic strokes with large vessel occlusion (LVO) in the anterior circulation. However, of 1287 patients enrolled in 5 trials, 94 with isolated second (M2) segment occlusions were randomized and 51 of these received EVT, thereby limiting evidence for treating isolated M2 segment occlusions as reflected in American Heart Association guidelines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research